Bhise MR, Bhajipale NS, Babu RH, Tare MS, et al. Comment on "Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes". Diabetes Obes Metab 2025 Nov 17. doi: 10.1111/dom.70294.
PMID: 41243568